For emergencies, call 113
Om du befinner deg i en krise eller har livstruende skader bør du ringe 113
About the HPV infection
There are about 200 different HPV strains of which approximately 40 are sexually transmitted. The majority of sexually active men and women will become infected with HPV at some point, mostly at a young age. Most people will not experience any symptoms, and in 9 out of 10 the HPV infections will disappear within 6 to 12 months without intervention. Chronic infections with some HPV strains may cause cervical cancer and other HPV-related cancers (e.g. vaginal, penile, anal, throat) after 10-20 years. To date, HPV is the only known cause of cervical cancer among which strain 16 and 18 account for approximately 70% of the cases. Some HPV strains cause benign genital warts (condyloma).
HPV vaccination in Norway
Since 2018, the HPV vaccine has been part of the national Childhood Immunisation Programme for girls and boys in 7th grade. The vaccine is injected in the upper arm, and two doses during 1 year are required for immunization. It is still unknown whether a booster dose is required, but to date we know that this regime will give good protection for at least 8 years. The vaccine is inactivated and does not contain traces of egg, chicken or mercury.
Who should take the HPV vaccine?
All young men and women are recommended to get the HPV vaccine.
There is no upper age limit for the HPV vaccine. The vaccine is not recommended if you are pregnant, are allergic to the vaccine or any of its content, or if you suffer from acute infection with fever. The vaccine does not give full protection against all HPV strains that may potentially cause cancerous changes, and there it is recommended that all women follow the national screening program from the age of 25.
Written by: General Practitioner Anne Marte Ladim
Last updated: 20. March 2020
Est. reading time: 1-2 minutes